血清C肽与糖化血红蛋白(HbA1c)联合检测在糖尿病患者临床诊断中的应用研究

Research on Application of Combined Test of Serum C Peptide and HbA1c in Clinical Diagnosis of Diabetes Patients

目的研究血清C肽与糖化血红蛋白(HbA1c)联合检测在糖尿病患者临床诊断中的应用价值。方法选择2017年2月—2018年2月该院收治的48例糖尿病患者作为试验组,选取同期48名健康体检者作为参照组,两组均接受HbA1c和血清C肽检测,并对检测结果进行比较。结果试验组HbA1c显著高于对照组,其血清C肽显著低于对照组,组间表现差异有统计学意义(P<0.05)。结论血清C肽与糖化血红蛋白(HbA1c)联合检测可显著提高糖尿病的临床诊断价值,并可为临床制定治疗方案和评价预后提供参考,值得借鉴和进一步推广。

Objective To research the application value of combined test of serum C peptide and HbA1c in clinical diagnosis of diabetes patients. Methods 48 cases of diabetes patients admitted and treated in our hospital from February 2017 to February 2018 were selected as the test group, while 48 cases of health physical examination people at the same period were selected as the control group, and both groups were for HbA1c and serum C peptide test, and the test results were compared between the two groups. Results The HbA1c in the test group was obviously higher than that in the control group,and the serum C peptide were obviously lower than those in the control group, and the differences between groups were statistically significant（P〈0.05）. Conclusion The combined test of serum C peptide and HbA1c can obviously improve the clinical diagnosis value of diabetes, which can provide reference for the clinical formulation of treatment plan and prognosis evaluation, and it is worth reference and further promotion.